Your browser doesn't support javascript.
loading
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
Moran, T; Wei, J; Cobo, M; Qian, X; Domine, M; Zou, Z; Bover, I; Wang, L; Provencio, M; Yu, L; Chaib, I; You, C; Massuti, B; Song, Y; Vergnenegre, A; Lu, H; Lopez-Vivanco, G; Hu, W; Robinet, G; Yan, J; Insa, A; Xu, X; Majem, M; Chen, X; de Las Peñas, R; Karachaliou, N; Sala, M A; Wu, Q; Isla, D; Zhou, Y; Baize, N; Zhang, F; Garde, J; Germonpre, P; Rauh, S; ALHusaini, H; Sanchez-Ronco, M; Drozdowskyj, A; Sanchez, J J; Camps, C; Liu, B; Rosell, R; Colinet, B; De Grève, J; Germonpré, P; Chen, H; Chen, X; Du, J; Gao, Y; Hu, J.
Affiliation
  • Moran T; Catalan Institute of Oncology, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Wei J; The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Cobo M; Medical Oncology Service, Hospital Carlos Haya, Malaga.
  • Qian X; The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Domine M; Medical Oncology Service, Fundacion Jimenez Diaz, Madrid.
  • Zou Z; The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Bover I; Medical Oncology Service, Hospital Son Llatzer, Palma de Mallorca.
  • Wang L; The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Provencio M; Medical Oncology Service, Hospital Puerta de Hierro, Madrid, Spain.
  • Yu L; The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Chaib I; Catalan Institute of Oncology, Medical Oncology Service, Hospital Germans Trias i Pujol, Badalona, Spain.
  • You C; Department of Oncology, Suqian General Hospital, Suqian, China.
  • Massuti B; Medical Oncology Service, Hospital General de Alicante, Alicante, Spain.
  • Song Y; Department of Pneumology, Jinling Hospital, Nanjing, China.
  • Vergnenegre A; Service de Pathologie Respiratoire et d'Allergologie, CHU Limoges, Limoges, France.
  • Lu H; Department of Pneumology, Taizhou General Hospital, Taizhou, China.
  • Lopez-Vivanco G; Medical Oncology Service, Hospital de Cruces, Bilbao, Spain.
  • Hu W; The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Robinet G; Service Pneumologie, CHU Brest, Brest, France.
  • Yan J; The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Insa A; Medical Oncology Service, Hospital Clinico de Valencia, Valencia, Spain.
  • Xu X; Department of Pneumology, Northern Jiangsu People's Hospital, Yangzhou, China.
  • Majem M; Medical Oncology Service, Hospital Sant Pau, Barcelona, Spain.
  • Chen X; Department of Oncology, Huaian General Hospital, Huaian, China.
  • de Las Peñas R; Medical Oncology Service, Hospital Provincial de Castellon, Castellon, Spain.
  • Karachaliou N; Translational Research Unit, Dr Rosell Oncology Institute, Quiron-Dexeus University Hospital, Barcelona.
  • Sala MA; Medical Oncology Service, Hospital de Basurto, Bilbao, Spain.
  • Wu Q; Department of Oncology, Yixin General Hospital, Yixin, China.
  • Isla D; Medical Oncology Service, Hospital Lozano Blesa, Zaragoza, Spain.
  • Zhou Y; Department of Oncology, Yixin General Hospital, Yixin, China.
  • Baize N; Department de Pneumologie, CHU Angers, Angers, France.
  • Zhang F; Department of Oncology, Maanshan General Hospital, Maanshan, China.
  • Garde J; Medical Oncology Service, Hospital Arnau de Vilanova, Valencia, Spain.
  • Germonpre P; Department of Pulmonary Medicine, Antwerp University Hospital, Edegem, Belgium.
  • Rauh S; Department of Internal Medicine and Oncology, Centre Hospitalier Emile Mayrisch, Luxembourg, Luxembourg.
  • ALHusaini H; Oncology Center, King Faisal Cancer Center, Riyadh, Saudi Arabia.
  • Sanchez-Ronco M; Department of Health and Medicosocial Sciences, University of Alcala, Madrid.
  • Drozdowskyj A; DMBS, PIVOTAL SL, Madrid.
  • Sanchez JJ; Department of Preventive Medicine, Autonomous University of Madrid, Madrid.
  • Camps C; Medical Oncology Service, Hospital General de Valencia, Valencia.
  • Liu B; The Comprehensive Cancer Centre, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
  • Rosell R; Catalan Institute of Oncology, Cancer Biology and Precision Medicine Program, Hospital Germans Trias i Pujol, Badalona; MORe Foundation, Barcelona, Spain; Cancer Therapeutic Innovation Group, New York,USA. Electronic address: rrosell@iconcologia.net.
Ann Oncol ; 25(11): 2147-2155, 2014 Nov.
Article de En | MEDLINE | ID: mdl-25164908
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines nucléaires / Protocoles de polychimiothérapie antinéoplasique / Protéines de transport / Carcinome pulmonaire non à petites cellules / Protéine BRCA1 Type d'étude: Clinical_trials Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2014 Type de document: Article Pays d'affiliation: Espagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines nucléaires / Protocoles de polychimiothérapie antinéoplasique / Protéines de transport / Carcinome pulmonaire non à petites cellules / Protéine BRCA1 Type d'étude: Clinical_trials Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2014 Type de document: Article Pays d'affiliation: Espagne